Clinical Trials Browser

Phase 2 × Pioglitazone × Clear all

NCT04794127 2026-02-18

TRABEPIO

Phase 2 Completed

Liposarcoma, Liposarcoma, Myxoid

NCT05919147 2025-07-04

TRACE-1

Phase 2 Active not recruiting

Lung Neoplasms

NCT05013255 2025-04-08

Pioglitazone Therapy Targeting Fatigue in Breast Cancer

Phase 2 Recruiting

Breast Neoplasms

NCT02852486 2025-03-30

EDI-PIO

Phase 2 Completed

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02942758 2024-05-08

AML-ViVA

Phase 2 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05394142 2024-04-22

SPIOMET4HEALTH

Phase 2 Unknown

Polycystic Ovary Syndrome

NCT04995978 2023-06-23

Insulin Resistance and Androgen Deprivation Therapy

Phase 2 Withdrawn

Insulin Resistance, Prostatic Neoplasms

NCT00099021 2022-02-11

Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia

Phase 2 Completed

21 enrolled 6 charts

Head and Neck Neoplasms, Leukoplakia, Oral

NCT04867252 2021-09-13

Effects of Combined Resveratrol and Myo-inositol on Altered Metabolic, Endocrine Parameters and Perceived Stress in Patients With Polycystic Ovarian Syndrome

Phase 2 Completed

Polycystic Ovary Syndrome

NCT04883125 2021-05-12

Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment

Phase 2 Completed

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT01838317 2021-03-01

A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas

Phase 2 Completed

14 enrolled 8 charts

Gastrointestinal

Pancreatic Neoplasms

NCT02347813 2020-06-23

Preventing Squamous Cell Skin Cancer

Phase 2 Completed

12 enrolled 10 charts

Carotid Intimal Medial Thickness 1, Carcinoma, Squamous Cell, Skin Neoplasms

NCT02730195 2019-01-09

Pioglitazone and Tyrosine Kinase Inhibitor in Treating Patients With Relapsed Chronic Myeloid Leukemia

Phase 2 Terminated

9 enrolled 8 charts

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02889003 2018-03-22

PIO2STOP

Phase 2 Unknown

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02852083 2018-01-18

ModuLung

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01342770 2017-12-05

Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer

Phase 2 Terminated

6 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT01655719 2017-10-26

Pioglitazone in Thyroid Cancers

Phase 2 Completed

1 enrolled 6 charts

EndocrineHead & Neck

Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene

NCT00427999 2016-11-21

INV342

Phase 2 Completed

67 enrolled 6 charts

Prostatic Neoplasms

NCT00951379 2016-04-06

Pioglitazone for Oral Premalignant Lesions

Phase 2 Terminated

52 enrolled 23 charts

Leukoplakia, Oral

NCT02687425 2016-02-22

SESPI

Phase 2 Unknown

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00923949 2015-09-30

Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer

Phase 2 Terminated

1 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung